Yahoo · Aug 27, 2026
Oncopeptides AB (FRA:OND) (Q2 2026) Earnings Call Highlights: Sales Surge 62% as European ...
Strong revenue growth and disciplined cost management position the company for positive cash flow in 2027, despite regional market challenges.

